Literature DB >> 10842346

Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents.

B Ongali1, A R Ase, C Hébert, F Amdiss, T A Reader.   

Abstract

Dystonia musculorum (dt(J)/dt(J)) mutant mice suffer from a degeneration of spinocerebellar tracts as well as a dystrophy of peripheral sensory tracts. This neurological mutant has been proposed as an animal model of human cerebellar ataxia, in particular of the Friedreich's type; thus, it was deemed of interest to examine the endogenous contents of dopamine (DA) and metabolites as well as the distribution of DA receptors of the D(1) and D(2) subtypes, in order to delimit the biochemical characteristics of this pathological disorder, and determine an eventual dopaminergic dysfunction in this mutant. Tissue DA and its major metabolites 3, 4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine were measured by HPLC coupled to electrochemical detection in six cortical regions, in four divisions of rostral neostriatum and two halves of caudal neostriatum, as well as in olfactory bulb, nucleus accumbens, septum, amygdala, hippocampus, thalamus, hypothalamus, brainstem, cerebellum, substantia nigra, and ventral tegmental area. The only significant difference between dt(J)/dt(J) mice and wild-type controls was an increase in hypothalamic DA contents (+47%). Quantitative autoradiography with [(3)H]SCH23390 and [(3)H]raclopride, to label D(1) and D(2) receptors, respectively, revealed only moderate changes in receptor densities in a few localized regions. In dt(J)/dt(J) mutants, D(1) receptor numbers were found to be higher in thalamus (+27%) as well as in the medio-dorsal (+16%) and in the latero-dorsal (+16%) quadrants of rostral neostriatum, while D(2) receptor densities were greater in the medio-ventral (+32%) and the latero-dorsal (+17%) quadrants. The present results indicate an overall conservation of dopaminergic functions, albeit the few localized sites of increased D(1) and D(2) receptor densities, and that are seemingly independent of the DA innervation pattern, as revealed by the tissue measurements of DA and metabolites. They also rule out a major pathology linked to deficits in DA neurotransmission, and validate this mutant as an animal model of human cerebellar ataxia, probably of the Friedreich type. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842346     DOI: 10.1002/(SICI)1098-2396(200007)37:1<1::AID-SYN1>3.0.CO;2-9

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  7 in total

1.  Distribution of dopamine, its metabolites, and D1 and D2 receptors in heterozygous and homozygous weaver mutant mice.

Authors:  T A Reader; A R Ase; C Hébert; F Amdiss
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex.

Authors:  P J Ebert; D B Campbell; P Levitt
Journal:  Neuroscience       Date:  2006-09-25       Impact factor: 3.590

3.  Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice.

Authors:  Lu-Tai Tien; Ing-Kang Ho; Horace H Loh; Tangeng Ma
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

4.  Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.

Authors:  Lisa M Davis; Michael Michaelides; Lawrence J Cheskin; Timothy H Moran; Susan Aja; Paul A Watkins; Zhengtong Pei; Carlo Contoreggi; Karen McCullough; Bruce Hope; Gene Jack Wang; Nora D Volkow; Panayotis K Thanos
Journal:  Neuroendocrinology       Date:  2008-11-04       Impact factor: 4.914

5.  Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS).

Authors:  Qing Liu; Adam C Puche; Jia Bei Wang
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

6.  Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.

Authors:  Sang Won Park; Xine Shen; Lu-Tai Tien; Richard Roman; Tangeng Ma
Journal:  J Biomed Sci       Date:  2011-11-10       Impact factor: 8.410

7.  Blockade of TRPV1 Inhibits Methamphetamine-induced Rewarding Effects.

Authors:  Yu-Hua Tian; Shi-Xun Ma; Kwang-Wook Lee; Sunmee Wee; George F Koob; Seok-Yong Lee; Choon-Gon Jang
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.